Age-related disorders are exacerbated by senescent cells (SnCs) due to their secretion of proinflammatory molecules, yet current therapeutic strategies have limited success in preclinical settings and clinical trials. A novel approach is needed to enhance SnCs clearance by targeting immune checkpoints, particularly the PD-1/PD-L1 axis, combined with tissue-specific delivery of therapeutic agents. This strategy is critical in reducing the chronic inflammation and improving tissue health in aging populations. However, challenges such as immune evasion by SnCs and potential autoimmune responses must be addressed. The aim of this manuscript is to propose a combined approach to improve the efficacy of senolytic therapy.
Impairment in social interactions is a prominent feature of autism spectrum disorder (ASD). The present hypothesis explains the possible role of vagal afferent stimulation in the modification of prefrontal-amygdala connectivity in the amelioration of social impairments in ASD. Currently, there is no definitive treatment for ASD. However, there is documented evidence showing that interventions that increase vagal tone lead to the improvement of autism-related social symptoms. However, the exact mechanism that explains the correlation between the elevation of vagal tone and the amelioration of autism-related symptoms has not been elucidated. In the present hypothesis, it is proposed that the increase in vagal tone affects the nucleus tractus solitarius (NTS) in the brainstem. The NTS has strong connections with other brainstem nuclei, such as the locus coeruleus and dorsal raphe nucleus. The aforementioned nuclei are the main sources of norepinephrine and serotonin, with extensive projections to various brain areas, especially the prefrontal cortex (PFC) and amygdala. PFC-amygdala functional connectivity plays an important role in social behavior and emotion regulation. Therefore, visceral stimulation, which subsequently increases the vagal tone, possibly leads to the improvement of autistic social deficits through the enhancement of PFC-amygdala functional connectivity. Further investigations are needed to evaluate the function of the mentioned neural pathways during visceral stimulation in individuals with ASD.
Lumbar disc herniation frequently causes low back pain and sciatica, significantly impacting patients’ quality of life. The pathogenesis of sciatica is complex, involving both mechanical compression and inflammatory processes. Recent studies have suggested a potential role of inflammatory mechanisms in the development of sciatica. We hypothesize that these inflammatory mediators contribute to the neuropathic pain experienced by patients with lumbar disc herniation. Understanding these inflammatory mechanisms may lead to novel therapeutic targets for managing sciatica in lumbar disc herniation, ultimately improving patient outcomes. Future research should focus on testing this hypothesis through scientific investigation to validate these potential new therapies.
The increasing rate of Carbapenem-resistant Enterobacteriaceaer (CRE) infections poses a significant threat to global public health. Patients infected with CRE often experience frequent recurrences after antibiotic treatment, making it difficult to cure. The design of better antimicrobials that can not only kill CRE but also disrupt biofilms and eliminate persister cells will play a crucial role in improving antibacterial efficacy and preventing recurrent infections. In this hypothesis, we employ an innovative “water pipe” theory to elucidate the potential underlying causes of CRE infection recurrence. We propose a potential therapeutic approach utilizing engineered phages to combat CRE infections, demonstrating the mechanism of action of phages carrying lytic enzymes or antimicrobial peptides against biofilms and persister cells. Furthermore, we evaluate its efficacy and feasibility, which may effectively address the recurrence of CRE infections and reduce antibiotic usage.